Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IQIJK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-HER2_VCGP-Dex
|
|||||
| Synonyms |
Anti-HER2_VCGP-Dex
Click to Show/Hide
|
|||||
| Organization |
Binghamton University, School of Pharmacy and Pharmaceutical Sciences, Binghamton, NY, USA.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
5.7
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Dexamethasone
|
Payload Info | ||||
| Therapeutic Target |
Glucocorticoid receptor (NR3C1)
|
Target Info | ||||
| Linker Name |
Mal-ValCitGlyPro-OH
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||